Open AccessApplicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial
Author(s) -
Salim S. Virani,
Julia M. Akeroyd,
Vijay Nambi,
Erin D. Michos,
Pamela B. Morris,
Khurram Nasir,
Sidney C. Smith,
Neil J. Stone,
Laura A. Petersen,
Christie M. Ballantyne
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.034993
Subject(s) - veterans affairs , medicine , subtilisin , family medicine , gerontology , biochemistry , chemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom